BeStock  
Markets › Compare › BCRX vs PBH

BCRX vs PBH

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BCRX · BioCryst Pharmaceuticals$7.22 ▼ 1.37%
PBH · Prestige Consumer Healthcare$49.63 ▲ 0.06%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

7094119143168Nov 24, '25May 26, '26Nov 20, '26
  • BCRX +5.7%
  • PBH -13.6%

Head to head

MetricBCRXPBH
Price$7.22$49.63
Change today▼ 1.37%▲ 0.06%
Market cap$1.86B$2.35B
Return, 3 months-25.4%-4.6%
Return, year to date-7.4%-19.5%
Return, 1 year+3.6%-16.5%
P/E (TTM)–15.3
P/B-4.71.2
P/E percentile vs own 5y70th39th
Dividend yield––
Revenue growth (YoY, latest qtr)+13.1%+22.7%
Net profit growth (YoY)+193.9%-40.1%
Gross margin97.9%52.5%
Operating margin42.5%25.0%
Net margin-37.4%13.3%
Return on equity–8.2%
Analyst target vs. price+135.5%+41.0%
Analyst buy share67%100%
RSI (14)3556
30-day volatility40.4%67.1%
Max drawdown, 1 year-35.0%-38.8%
Trend readStrong downtrendLeaning bullish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • PBH is the largest of the group by market value.
  • BCRX has returned the most over the past year.
  • PBH is growing revenue fastest.
  • PBH keeps the most profit per dollar of sales.
  • BCRX has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top